GSK plc

GB

GSK

Health Care

40.59 ₽

Current price

Hold
40.59 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    439 / 1328

  • Position in country

    882 / 1912

  • Return on Assets, %

    8.9

    -2.7

  • Net income margin, %

    4.9

    2.8

  • EBITDA margin, %

    12.3

    10.8

  • Debt to Equity, %

    134.9

    19.2

  • Intangible assets and goodwill, %

    36.5

    3.6

  • Revenue CAGR 3Y, %

    7.5

    8.5

  • Total Equity change 1Y, %

    32.5

    0

  • Revenue Y, % chg

    6.5

    0.5

  • P/E

    13.5

    22.7

  • P/BV

    4.9

    1.5

  • P/S

    2.2

    2.3

  • EV/S

    2.6

    2.4

  • EV/EBITDA

    8.6

    7.4

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    11.9

    51.3

  • Forward P/E

    9.9

    15.6

  • Dividend Yield, %

    3.6

    1.7

  • Forward Dividend Yield, %

    3.7

    0.2

  • Expected dividend per share

    1.5

    0

  • Payout Ratio, %

    47.7

    30.3

  • Dividend Ex Date

    2024-02-22

Get an analytical review of this company

Competitors

Ranks

  • Novo Nordisk A/S

    00%

  • AstraZeneca PLC

    00%

  • Indivior PLC

    00%

  • GSK plc

    00%

  • Verona Pharma PLC

    00%

  • Eli Lilly and Co

    00%

  • Hikma Pharmaceuticals PLC

    00%

  • Johnson & Johnson

    00%

  • Merck & Co Inc

    00%

  • Dechra Pharmaceuticals Ltd

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United Kingdom

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    85492.2

  • Ticker

    GSK.N

  • ISIN

    US37733W2044

  • IPO date

    1972-05-22

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-03-01

  • Date fact. publication of reports

    2023-12-31

Company Description

GlaxoSmithKline PLC is a global healthcare company. The Company researches and develops a range of products in three primary areas: Pharmaceuticals, Vaccines and Consumer Healthcare. Its product formulations include tablets, creams/ointments, inhalers, injections, liquids and sterile products. Its Pharmaceuticals business has a portfolio of established medicines in respiratory, human immunodeficiency virus (HIV), immuno-inflammation and oncology. Its Vaccines business has a portfolio of vaccines to help protect people from a range of diseases throughout their lives. Its vaccines tackle diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and influenza. Its Consumer Healthcare business combines science and consumer insights to create everyday healthcare brands that consumers trust, and experts recommend for oral health, pain relief, cold, flu and allergy, digestive health and vitamins, minerals and supplements.